Cargando…

An Analysis of the Social and Economic Costs of Breast Cancer in Italy

Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs bor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mennini, Francesco Saverio, Trabucco Aurilio, Marco, Gazzillo, Simone, Nardone, Claudia, Sciattella, Paolo, Marcellusi, Andrea, Migliorini, Raffaele, Sciannamea, Valerio, Piccioni, Andrea, Bolcato, Matteo, Barni, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431604/ https://www.ncbi.nlm.nih.gov/pubmed/34501588 http://dx.doi.org/10.3390/ijerph18179005

Ejemplares similares

Health and Economic Impact of Atrial Fibrillation of Workers in Italy: Social Security Benefits
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy
por: Mennini, Francesco S, et al.
Publicado: (2018)

Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic
por: Trabucco Aurilio, Marco, et al.
Publicado: (2021)

Socio-economic impact of epilepsy in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Economic aspects in the management of diabetes in Italy
por: Marcellusi, A, et al.
Publicado: (2016)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2012)

Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2013)

Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
por: Marcellusi, A., et al.
Publicado: (2021)

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2022)

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2018)

Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
por: Fabiano, G., et al.
Publicado: (2022)

Organizational Strategies for the Management of Intravenous Iron Therapy in Non-Hospitalized Settings: A Safe Opportunity to Implement Patient Blood Management in Italy
por: Bolcato, Matteo, et al.
Publicado: (2021)

Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache centre
por: Negro, Andrea, et al.
Publicado: (2020)

Estimation of the number of HCV-positive patients in Italy
por: Gardini, Ivan, et al.
Publicado: (2019)

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Main Predictors of COVID-19 Vaccination Uptake among Italian Healthcare Workers in Relation to Variable Degrees of Hesitancy: Result from a Cross-Sectional Online Survey
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

The Difficult Balance between Ensuring the Right of Nursing Home Residents to Communication and Their Safety
por: Bolcato, Matteo, et al.
Publicado: (2021)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2014)

Cost of illness del carcinoma cutaneo a cellule squamose (CSCC)
por: Marcellusi, Andrea, et al.
Publicado: (2020)

Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre
por: Negro, Andrea, et al.
Publicado: (2019)

Evaluation of Immunity for Mumps among Vaccinated Medical Students
por: Ferrari, Cristiana, et al.
Publicado: (2021)

Costo-efficacia di IMI/CIL/REL rispetto a CMS+IMI per il trattamento di infezioni batteriche Gram-negative non sensibili ai carbapenemi
por: Paoletti, Martina, et al.
Publicado: (2023)

First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers
por: Coppeta, Luca, et al.
Publicado: (2021)

Valutazione delle conseguenze epidemiologiche ed economiche generate dal ritardo di trattamento dei pazienti HIV-positivi causato dalla pandemia COVID-19
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Take-Home Messages from the COVID-19 Pandemic: Strengths and Pitfalls of the Italian National Health Service from a Medico-Legal Point of View
por: Bolcato, Matteo, et al.
Publicado: (2020)

Analisi di impatto di budget di un nuovo sistema di cura in pazienti affetti da malattia di Parkinson
por: Bini, Chiara, et al.
Publicado: (2022)

Valutazione economica di treosulfan in pazienti sottoposti a trapianto allogenico di cellule staminali ematopoietiche
por: Bini, Chiara, et al.
Publicado: (2022)

Improving care through health economics analyses: cost of illness and headache
por: Mennini, Francesco Saverio, et al.
Publicado: (2008)

Analisi di costo-utilità di ceftolozano/tazobactam rispetto a meropenem in pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP)
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy
por: Sciattella, Paolo, et al.
Publicado: (2021)

COVID-19 Pandemic and Equal Access to Vaccines
por: Bolcato, Matteo, et al.
Publicado: (2021)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021)

The costs of headache disorders
por: Mennini, Francesco Saverio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_heasvees6s967p4bpat9mprjqr